| 國立臺灣大學 |
2003 |
Urodynamically Age-Specific Prevalence of Urinary Incontinence in Women with Urinary Symptoms
|
林鶴雄; 童寶玲; 許博欽; 邵文逸; 黃思誠; LIN, HO-HSIUNG; TORNG, PAO-LING; SHEU, BOR-CHING; SHAU, WEN-YI; HUANG, SU-CHENG |
| 臺大學術典藏 |
2003 |
Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms
|
Lin, H.-H. and Torng, P.-L. and Sheu, B.-C. and Shau, W.-Y. and Huang, S.-C.; PAO-LING TORNG; HO-HSIUNG LIN; BOR-CHING SHEU |
| 臺大學術典藏 |
2020-01-22T06:00:35Z |
Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms
|
Huang S.-C.; Shau W.-Y.; BOR-CHING SHEU; Torng P.-L.; Lin H.-H.; Lin H.-H.;Torng P.-L.;Bor-Ching Sheu;Shau W.-Y.;Huang S.-C. |
| 臺大學術典藏 |
2020-02-17T08:51:06Z |
Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms
|
HO-HSIUNG LIN; Torng P.-L; Sheu B.-C; Shau W.-Y; Huang S.-C. |
| 臺大學術典藏 |
2021-03-03T03:01:23Z |
Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms
|
Ho-Hsiung Lin;Torng P.-L.;Sheu B.-C.;Shau W.-Y.;Huang S.-C.; HO-HSIUNG LIN; Torng P.-L.; Sheu B.-C.; Shau W.-Y.; Huang S.-C. |
| 臺大學術典藏 |
2020-02-17T08:51:06Z |
Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms
|
HO-HSIUNG LIN; Torng P.-L; Sheu B.-C; Shau W.-Y; Huang S.-C. |
| 中國醫藥大學 |
2013-04-20 |
Uroepithelial dysfunction—OAB
|
鄒頡龍(Chieh-Lung Chou)* |
| 臺大學術典藏 |
2022-07-12T05:28:49Z |
Uroflowmetry and postvoid residual urine tests in incontinent children
|
Yang S.S.-D.; SHANG-JEN CHANG |
| 臺北醫學大學 |
2011 |
Urogen 50mgtab 抑炎源 錠
|
藥劑部藥師 |
| 中國醫藥大學 |
2004 |
Urokinase gene 3 '-UTR T/C polymorphism is associated with oral cancer
|
Tsai, MH; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2004 |
Urokinase gene 3 '-UTR T/C polymorphism is associated with oral cancer
|
Tsai, MH; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2002 |
Urokinase gene 3 '-UTR T/C polymorphism is associated with urolithiasis
|
Tsai, FJ; Lin, CC; Lu, HF; Chen, HY; Chen, WC |
| 中國醫藥大學 |
2002 |
Urokinase gene 3 '-UTR T/C polymorphism is associated with urolithiasis
|
Tsai, FJ; Lin, CC; Lu, HF; Chen, HY; Chen, WC |
| 中國醫藥大學 |
2002 |
Urokinase Gene 3'-UTR T/C Polymorphism is Associated with Urolithiasis
|
蔡輔仁(Fuu-Jen Tsai); 林正介(Cheng-Chieh Lin); (Hsueh-Fu Lu); 陳慧毅(Huey-Yi Chen); (Wen-Chi Chen) |
| 中國醫藥大學 |
2004 |
Urokinase gene 3'-UTR T/C polymorphism is not associated with bladder cancer
|
(Hsi-Chin Wu); (Chao-Hsiang Chang); 陳汶吉(Chen Wen-Chi); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2004 |
Urokinase gene 3'-UTR T/C polymorphism is not associated with bladder cancer
|
Wu, HC; Chang, CH; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2004 |
Urokinase gene 3'-UTR T/C polymorphism is not associated with bladder cancer
|
Wu, HC; Chang, CH; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2004-07 |
Urokinase gene 3-UTR T/C polymorphism is associated with oral cancer
|
蔡銘修(Ming-Hsui Tsai); 陳汶吉(Chen Wen-Chi); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2002 |
Urokinase gene 3’-UTR C/T polymorphism is associated with Urolithiasis
|
蔡輔仁(Fuu-Jen Tsai); 陳慧毅(Huey-Yi Chen); 呂學甫(Lu HF); 許正德(Hsu CD); 陳汶吉(Chen Wen-Chi)* |
| 中國醫藥大學 |
2004 |
Urokinase Gene 3’-UTR T/C Polymorphism Is Not Associated With Bladder Cancer.
|
吳錫金(Hsi-Chin Wu); 張兆祥(Chao-Hsiang Chang); 陳汶吉(Chen Wen-Chi); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2002 |
Urokinase gene 3′-UTR T/C polymorphism is associated with urolithiasis
|
蔡輔仁(Fuu-Jen Tsai); 林正介(Cheng-Chieh Lin); (Lu HF); 陳慧毅(Huey-Yi Chen); 陳汶吉(Chen Wen-Chi) |
| 國立臺灣大學 |
2015 |
Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients
|
Huang, Chia-Yen; Chang, Ming-Cheng; Huang, Wei-Yun; Huang, Ching-Ting; Tang, Yu-Chien; Huang, Hsien-Da; Kuo, Kuan-Ting; Chen, Chi-An; Cheng, Wen-Fang; 鄭文芳; 郭冠廷; 陳祈安 |
| 臺大學術典藏 |
2020-01-22T07:50:28Z |
Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients
|
Cheng W.-F.; CHI-AN CHEN; Kuo K.-T.; Huang H.-D.; Tang Y.-C.; Huang C.-T.; Huang W.-Y.; Chang M.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients
|
WEN-FANG CHENG;Chen C.-A.;Kuo K.-T.;Huang H.-D.;Tang Y.-C.;Huang C.-T.;Huang W.-Y.;Chang M.-C.;Huang C.-Y.; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-03-07T06:42:08Z |
Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients
|
Huang C.-Y.;Chang M.-C.;Huang W.-Y.;Huang C.-T.;Tang Y.-C.;Huang H.-D.;Kuan-Ting Kuo;Chen C.-A.;Cheng W.-F.; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; KUAN-TING KUO; Chen C.-A.; Cheng W.-F. |
